Leadership Volatility in CGT CDMOs: A Strategic Flashpoint
The last 18 months have sent ripples through the executive leadership ranks of cell and gene therapy (CGT) CDMOs. Site Heads. Vice Presidents of Operations. General Managers. Titles may vary, but the story is consistent: turnover is high, and the stakes have never been higher. Behind the scenes of manufacturing partnerships and clinical progress, a […]